HPV_vaccine_teen_boy_WEB.jpg

Improving HPV Vaccination Rates 


Vaccine-vials-and-syringe_WEB.jpgHPV vaccination is cancer prevention. According to the Centers for Disease Control and Prevention (CDC), HPV is estimated to cause nearly 35,000 cases of cancer in men and women every year in the U.S. HPV vaccination can prevent more than 32,000 of these cancers from ever developing by preventing the infections that cause those cancers.

Quality Insights is partnering with the Delaware Division of Public Health in a statewide initiative to provide NO-COST education, training, and resources to health care practices in an effort to increase HPV vaccination rates. To learn more, please download the HPV project flyer.
 

QI-01-(1).jpgWhat Quality Insights Offers:

  * Academic Detailing for Providers
  * Data Reconciliation
  * Postcard Reminder Campaigns
  * Ongoing Technical Assistance
                                     * DelVAX Assistance
                                     * Individualized Education
                                     * Evidence-Based Workflow Modification Assistance
                                     * Proven Results
 

Clinician-Engagement-01.jpgGuidelines for Participation

  * Designate an individual to act as the primary contact for           Quality Insights
  * Actively participate in a staff training provided by Quality
     Insights
                                     * Serve pediatric/adolescent patients and provide
                                        adolescent immunizations
                                     * Share educational materials provided by Quality Insights
                                        with your staff and patients/parents
                                     * Currently report or develop a process to report
                                        immunizations to DelVAX  to comply with state law
 

AdvancingCare-01-(1).jpgBenefits and Delivered Results

  * 8.1% average increase in HPV vaccine initiation
     across engaged sites, with one practice achieving an 18%
     increase
  * 15.5% average increase in HPV up-to-date (UTD)
                                        vaccination
for the 13-17 year old cohort, with one
                                        practice achieving a 24% increase
                                     * Increased understanding and utilization of DelVAX
                                        through onsite training
                                     * Adoption of evidence-based workflow modifications
                                        to ensure HPV vaccination is a priority 
                                     * Tailored presentations and resources to meet your
                                        practice’s needs

cell-phone-icon-(1).pngContact Us

If you are interested in participating in this program or would like more information, please email Sarah Toborowski or call 1.302.290.9049.


Your participation in this work creates a foundation for your practice’s quality improvement efforts and prepares your practice for future value-based payment models.